Related Experiment Video
Updated: Jan 14, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Comprehensive Review of Phytotherapeutic Methods for Treating tuberculosis
Reetu Chauhan1, Shikha Sharma1, Jagdish K Sahu2
1Department of Pharmaceutical Science, Lords University, Chikani, Alwar, 301028, Rajasthan, India.
Abstract:
Medicinal plants are a rich source of therapeutic agents. Tuberculosis (TB) is a highly infectious disease causing significant morbidity and mortality, primarily due to its causative agent, Mycobacterium tuberculosis. The incidence of TB is rising globally, exacerbated by the emergence of drug-resistant strains. Resistance has developed against first-line and second-line drugs, compli-cating TB control programmes and diminishing their effectiveness. The development of Multi-Drug-Resistant (MDR) and extensively-Drug-Resistant (XDR) strains of Mycobacterium tubercu-losis highlights the urgent need for novel anti-TB drugs with unique mechanisms of action. Medic-inal plants present promising alternative sources for TB treatment, especially for MDR and XDR strains. These plants produce various secondary metabolites, such as alkaloids, coumarins, flavo-noids, polyphenols, terpenoids, and quinones, which exhibit antimicrobial properties. These com-pounds, while not directly involved in the plant's growth and development, serve as defence mech-anisms and hold potential for TB control. According to the literature, phytochemical constituents with anti-tubercular activity have been identified in various plants. These phytochemicals show promise in treating MDR and XDR TB. This review provides an overview of the current synthetic drugs used for TB treatment and highlights the work done on anti-tubercular plants and their phyto-chemicals.
More Related Videos
09:57Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria
Published on: December 14, 2016
10:29A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...